Syncom Formulations (India) Ltd Surges in Stock Market, Outperforms Sector and Sensex
Syncom Formulations (India) Ltd, a smallcap pharmaceutical company, has seen a surge in its stock price, hitting a 52-week high of Rs. 24.44 on September 9th. The stock has outperformed the sector by 3.85% and has been on a consecutive gain for the last 4 days, with a 19.83% increase in returns. With a strong upward trend and impressive performance, the company is a promising player in the pharmaceutical industry.
Syncom Formulations (India) Ltd, a smallcap pharmaceutical company, has been making waves in the stock market with its recent surge in share price. On September 9th, the company's stock hit a 52-week high of Rs. 24.44, marking a significant milestone for the company.
This positive trend has caught the attention of market experts, with MarketsMOJO giving a 'Buy' call for Syncom Formulations (India) Ltd. The stock has also outperformed the sector by 3.85% and has been on a consecutive gain for the last 4 days, with a 19.83% increase in returns during this period.
In addition, the company's stock is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong upward trend. This is a promising sign for investors looking to capitalize on the company's growth potential.
In terms of overall performance, Syncom Formulations (India) Ltd has shown an impressive 176.97% increase in the past year, outperforming the Sensex's 21.84% performance. This further solidifies the company's position as a strong player in the pharmaceutical industry.
With its consistent growth and positive market sentiment, Syncom Formulations (India) Ltd is definitely a stock to watch out for. As a smallcap company, it has shown great potential for growth and is definitely worth considering for investors looking to diversify their portfolio in the pharmaceutical and drugs sector.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
